BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 1944424)

  • 1. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.
    Soudah HC; Hasler WL; Owyang C
    N Engl J Med; 1991 Nov; 325(21):1461-7. PubMed ID: 1944424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interdigestive motor activity in patients with systemic sclerosis.
    Rees WD; Leigh RJ; Christofides ND; Bloom SR; Turnberg LA
    Gastroenterology; 1982 Sep; 83(3):575-80. PubMed ID: 6124475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of erythromycin on gastric and gallbladder emptying and gastrointestinal symptoms in scleroderma patients is maintained medium term.
    Fiorucci S; Distrutti E; Gerli R; Morelli A
    Am J Gastroenterol; 1994 Apr; 89(4):550-5. PubMed ID: 8147358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Octreotide in gastrointestinal motility disorders.
    Owyang C
    Gut; 1994; 35(3 Suppl):S11-4. PubMed ID: 8206395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis.
    Chang CS; Chen GH; Lien HC; Yeh HZ
    Hepatology; 1998 Nov; 28(5):1187-90. PubMed ID: 9794900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global improvement of systemic scleroderma under long-term administration of octreotide.
    Descamps V; Duval X; Crickx B; Bouscarat F; Coffin B; Belaich S
    Eur J Dermatol; 1999 Sep; 9(6):446-8. PubMed ID: 10491499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of intestinal manometry in gastrointestinal pathology].
    Madrid AM; Quera R; Defilippi C
    Rev Med Chil; 1999 Oct; 127(10):1176-82. PubMed ID: 10835733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
    Saslow SB; O'Brien MD; Camilleri M; von der Ohe M; Homburger HA; Klee GG; Pitot HC; Rubin J
    Am J Gastroenterol; 1997 Dec; 92(12):2250-6. PubMed ID: 9399764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small intestinal bacterial overgrowth in systemic sclerosis.
    Marie I; Ducrotté P; Denis P; Menard JF; Levesque H
    Rheumatology (Oxford); 2009 Oct; 48(10):1314-9. PubMed ID: 19696066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine.
    Vantrappen G; Janssens J; Hellemans J; Ghoos Y
    J Clin Invest; 1977 Jun; 59(6):1158-66. PubMed ID: 864008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small intestinal manometry in patients with systemic sclerosis.
    Sjölund K; Bartosik I; Lindberg G; Scheja A; Wildt M; Akesson A
    Eur J Gastroenterol Hepatol; 2005 Nov; 17(11):1205-12. PubMed ID: 16215433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further classification of dysmotility-like dyspepsia by interdigestive gastroduodenal manometry and plasma motilin level.
    Kusano M; Sekiguchi T; Kawamura O; Kikuchi K; Miyazaki M; Tsunoda T; Horikoshi T; Mori M
    Am J Gastroenterol; 1997 Mar; 92(3):481-4. PubMed ID: 9068474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of small intestinal disease in systemic sclerosis with octreotide: a prospective study in seven patients.
    Nikou GC; Toumpanakis C; Katsiari C; Charalambopoulos D; Sfikakis PP
    J Clin Rheumatol; 2007 Jun; 13(3):119-23. PubMed ID: 17551375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.
    Pimentel M; Chow EJ; Lin HC
    Am J Gastroenterol; 2000 Dec; 95(12):3503-6. PubMed ID: 11151884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma].
    Folwaczny C; Läritz M; Meurer M; Endres SP; König A; Schindlbeck N
    Z Gastroenterol; 1997 Oct; 35(10):905-12. PubMed ID: 9432812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endogenous ethanol production in patients with liver cirrhosis, motor alteration and bacterial overgrowth].
    Madrid AM; Hurtado C; Gatica S; Chacón I; Toyos A; Defilippi C
    Rev Med Chil; 2002 Dec; 130(12):1329-34. PubMed ID: 12611233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of small-bowel motor impairment in systemic sclerosis--a prospective manometric 5-yr follow-up.
    Marie I; Ducrotté P; Denis P; Hellot MF; Levesque H
    Rheumatology (Oxford); 2007 Jan; 46(1):150-3. PubMed ID: 16782730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of intestinal dysmotility and stasis by octreotide early after small-bowel autotransplantation in dogs.
    Nakada K; Ikoma A; Suzuki T; Reynolds JC; Campbell WL; Todo S; Starzl TE
    Am J Surg; 1995 Mar; 169(3):294-9. PubMed ID: 7879829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function.
    Madrid AM; Hurtado C; Venegas M; Cumsille F; Defilippi C
    Am J Gastroenterol; 2001 Apr; 96(4):1251-5. PubMed ID: 11316178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hydrogen (H2) breath tests in the diagnosis of small intestine diseases].
    Wildgrube HJ; Classen M
    Z Gastroenterol; 1983 Nov; 21(11):628-36. PubMed ID: 6659630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.